omega-n-methylarginine has been researched along with Allergic Angiitis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Booth, AD; Brown, J; Jayne, DR; Kharbanda, RK; Mackenzie, IS; McEniery, CM; Wilkinson, IB | 1 |
1 trial(s) available for omega-n-methylarginine and Allergic Angiitis
| Article | Year |
|---|---|
Infliximab improves endothelial dysfunction in systemic vasculitis: a model of vascular inflammation.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Antineutrophil Cytoplasmic; Antibodies, Monoclonal; Autoimmune Diseases; C-Reactive Protein; Churg-Strauss Syndrome; Cohort Studies; Cyclophosphamide; Drug Therapy, Combination; Endothelium, Vascular; Enzyme Inhibitors; Female; Forearm; Granulomatosis with Polyangiitis; Humans; Immunosuppressive Agents; Infliximab; Interleukin-6; Male; Middle Aged; Mycophenolic Acid; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; omega-N-Methylarginine; Pilot Projects; Plethysmography; Prednisolone; Regional Blood Flow; Tumor Necrosis Factor-alpha; Vasculitis | 2004 |